Shaoyi Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shaoyi Zhang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Fengbiao Guo
Institute of Chinese Medical Sciences, State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau, Macau, China
2 shared publicationsAbigail L. Toren
Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
1 shared publicationAnn Hanna
Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
1 shared publication- Ayaka Sugiura
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication - Bin Li
Jiangsu Province Engineering Research Center of TCM Health Preservation, Nanjing University of Chinese Medicine, Nanjing, China
1 shared publication Brandie C. Taylor
Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
1 shared publication
Latest Publications
- Open Access
- 11 July 2026
- Published by Springer Nature in Oncogenesis
- Vol. 15 (1)
Lung adenocarcinoma cell-derived lactate activates CAFs to promote macrophage M2 polarization via exosomal miR-214-5p
Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment that can drive cancer progression and immune evasion. Here, we identify a novel pathway in which lactate produced by lung adenocarcinoma (LUAD) cells activates normal fibroblasts into CAFs, inducing high expression of microRNA miR-214-5p. The CAFs secrete miR-214-5p via exosomes, which in turn polarizes tumor-associated macrophages (TAMs) toward the immunosuppressive M2 phenotype. Mechanistically, exosomal miR-214-5p targets the transcriptional repressor BHLHE41 in macrophages, relieving its inhibition on M2-polarization genes. We further demonstrate that lactate accumulation epigenetically upregulates miR-214-5p in CAFs by increasing histone H3 lysine 9 lactylation (H3K9la) at the DNM3OS/miR-214 gene locus, independently of the lactate receptor GPR81. Lactate also enhances the loading of miR-214-5p into exosomes by inducing lactylation of the RNA-binding protein YBX1, which binds miR-214-5p and facilitates its exosomal export. In a mouse co-implantation model of LUAD, pharmacological blockade of tumor lactate production (LDH inhibition) reduced CAF activation, TAM M2 polarization, miR-214-5p levels, and tumor growth. Our findings uncover a lactate-driven CAF-TAM signaling axis via exosomal miR-214-5p, highlighting potential therapeutic targets to counteract tumor immune evasion in lung adenocarcinoma.
- 11 July 2026
- Published by Springer Nature in Oncogenesis
- Vol. 15 (1)
Open AccessLung adenocarcinoma cell-derived lactate activates CAFs to promote macrophage M2 polarization via exosomal miR-214-5p
Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment that can drive cancer progression and immune evasion. Here, we identify a novel pathway in which lactate produced by lung adenocarcinoma (LUAD) cells activates normal fibroblasts into CAFs, inducing high expression of microRNA miR-214-5p. The CAFs secrete miR-214-5p via exosomes, which in turn polarizes tumor-associated macrophages (TAMs) toward the immunosuppressive M2 phenotype. Mechanistically, exosomal miR-214-5p targets the transcriptional repressor BHLHE41 in macrophages, relieving its inhibition on M2-polarization genes. We further demonstrate that lactate accumulation epigenetically upregulates miR-214-5p in CAFs by increasing histone H3 lysine 9 lactylation (H3K9la) at the DNM3OS/miR-214 gene locus, independently of the lactate receptor GPR81. Lactate also enhances the loading of miR-214-5p into exosomes by inducing lactylation of the RNA-binding protein YBX1, which binds miR-214-5p and facilitates its exosomal export. In a mouse co-implantation model of LUAD, pharmacological blockade of tumor lactate production (LDH inhibition) reduced CAF activation, TAM M2 polarization, miR-214-5p levels, and tumor growth. Our findings uncover a lactate-driven CAF-TAM signaling axis via exosomal miR-214-5p, highlighting potential therapeutic targets to counteract tumor immune evasion in lung adenocarcinoma.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Role of Chloride in Modulating Autophagy : Cystic Fibrosis as a Disease Model
Rôle du chlorure dans la modulation de l'autophagie : la mucoviscidose en tant que modèle de maladie: Les niveaux de chlorure sont rigoureusement régulés par des canaux de chlorure tels que le régulateur transmembranaire de mucoviscidose (CFTR), la famille de canaux CLC ou les canaux de chlorure activés par le calcium. Un dérèglement des concentrations de chlorure ou du transport de ce dernier a été rapportée pour être lié à plusieurs maladies telles que la mucoviscidose, la myotonie, l'épilepsie, l'hyperekplexie ou la surdité. Toutes ces maladies appartiennent à la famille des pathologies qui présentent un déficit de la fonction lysosomale et qui sont caractérisées par un défaut du processus autophagique.Les cellules épithéliales pulmonaires des malades atteints de mucoviscidose montrent également un défaut d’autophagie. L’association de deux produits : la cysteamine et l’epigallocathecin gallate (EGCG) permet de restaurer la fonction autophagique de ces cellules et améliore les symptômes de la maladie. Nous avons tenté d'améliorer cette combinaison en criblant des inducteurs de l'autophagie pour leur capacité d’interaction avec la cystéamine et pour une meilleure efficacité de traitement. Nous avons ainsi trouvé que l'amiodarone, de manière similaire à l'EGCG, était capable d'engager une interaction coopérative avec la cystéamine pour stimuler l'autophagie dans les lignées cellulaires. De plus, l'amiodarone s’est révélé relativement efficace pour restaurer l'expression d’une protéine Del 508 CFTR mature et fonctionnelle dans les cellules épithéliales.Dans la deuxième partie de cette thèse, nous avons exploré les relations entre la modulation des concentrations intracellulaires des ions chlorure et l'autophagie. Trois approches complémentaires ont été utilisées (i) l’appauvrissement / réduction du chlorure dans le milieu de culture des cellulaires (ii) la réduction de l'expression du gène CLCN7 codant pour le seul transporteur de chlorure connu pour être présent dans les lysosomes et (iii) l’utilisation de transporteurs synthétique des ions chlorure. Nous avons montré que la modulation de la concentration des ions Cl- régulait l'autophagie. Cela a été observé lorsque nous avons déplété le chlorure du milieu de culture cellulaire ou lorsque nous avons aboli le gradient de chlorure en utilisant des transporteurs de chlorure synthétique (SCTs). Nous avons également montré que les STCs modifiaient la structure et la fonction des mitochondries. De plus, nous avons montré que les antioxydants restauraient la fonction mitochondriale et inhibaient la stimulation de l'autophagie, ce qui permet de voir sous un jour nouveau le rôle que le chlorure pourrait jouer dans la signalisation de différentes voies cellulaire de réponse au stress.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Role of Chloride in Modulating Autophagy : Cystic Fibrosis as a Disease Model
Rôle du chlorure dans la modulation de l'autophagie : la mucoviscidose en tant que modèle de maladie: Les niveaux de chlorure sont rigoureusement régulés par des canaux de chlorure tels que le régulateur transmembranaire de mucoviscidose (CFTR), la famille de canaux CLC ou les canaux de chlorure activés par le calcium. Un dérèglement des concentrations de chlorure ou du transport de ce dernier a été rapportée pour être lié à plusieurs maladies telles que la mucoviscidose, la myotonie, l'épilepsie, l'hyperekplexie ou la surdité. Toutes ces maladies appartiennent à la famille des pathologies qui présentent un déficit de la fonction lysosomale et qui sont caractérisées par un défaut du processus autophagique.Les cellules épithéliales pulmonaires des malades atteints de mucoviscidose montrent également un défaut d’autophagie. L’association de deux produits : la cysteamine et l’epigallocathecin gallate (EGCG) permet de restaurer la fonction autophagique de ces cellules et améliore les symptômes de la maladie. Nous avons tenté d'améliorer cette combinaison en criblant des inducteurs de l'autophagie pour leur capacité d’interaction avec la cystéamine et pour une meilleure efficacité de traitement. Nous avons ainsi trouvé que l'amiodarone, de manière similaire à l'EGCG, était capable d'engager une interaction coopérative avec la cystéamine pour stimuler l'autophagie dans les lignées cellulaires. De plus, l'amiodarone s’est révélé relativement efficace pour restaurer l'expression d’une protéine Del 508 CFTR mature et fonctionnelle dans les cellules épithéliales.Dans la deuxième partie de cette thèse, nous avons exploré les relations entre la modulation des concentrations intracellulaires des ions chlorure et l'autophagie. Trois approches complémentaires ont été utilisées (i) l’appauvrissement / réduction du chlorure dans le milieu de culture des cellulaires (ii) la réduction de l'expression du gène CLCN7 codant pour le seul transporteur de chlorure connu pour être présent dans les lysosomes et (iii) l’utilisation de transporteurs synthétique des ions chlorure. Nous avons montré que la modulation de la concentration des ions Cl- régulait l'autophagie. Cela a été observé lorsque nous avons déplété le chlorure du milieu de culture cellulaire ou lorsque nous avons aboli le gradient de chlorure en utilisant des transporteurs de chlorure synthétique (SCTs). Nous avons également montré que les STCs modifiaient la structure et la fonction des mitochondries. De plus, nous avons montré que les antioxydants restauraient la fonction mitochondriale et inhibaient la stimulation de l'autophagie, ce qui permet de voir sous un jour nouveau le rôle que le chlorure pourrait jouer dans la signalisation de différentes voies cellulaire de réponse au stress.
- Open Access
- 7 February 2026
- Published by Elsevier in Intestinal Failure
- Vol. 10, 100355
Microbiota-oriented strategies to mitigate parenteral nutrition–related complications in intestinal failure: A narrative review
- 7 February 2026
- Published by Elsevier in Intestinal Failure
- Vol. 10, 100355
Open AccessMicrobiota-oriented strategies to mitigate parenteral nutrition–related complications in intestinal failure: A narrative review
- Open Access
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1696587
A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells
CD4 + Foxp3 + regulatory T cells (Tregs) are essential for maintaining immune tolerance, and selective expansion of Tregs via TNFR2 signaling represents a promising therapeutic approach for autoimmune and inflammatory diseases. Here, we report the identification and characterization of UMR2-705, a novel TNFR2 agonist discovered through phage display screening. In vitro , peptide UMR2–705 selectively promoted Treg proliferation in both human peripheral blood mononuclear cells and murine CD4 + T cell cultures without stimulating conventional CD4 + effector or CD8 + T cells. This effect was abrogated by the TNFR2-specific blocking antibody TR75-54.7, indicating its TNFR2 dependency. In vivo , administration of peptide UMR2–705 expanded Tregs in murine spleen and lymph nodes, attenuated LPS-induced systemic cytokine release (IL-6, TNF-α, IL-17A) in serum, and preserved immune homeostasis during systemic inflammation through TNFR2-dependent modulation of the regulatory compartment. Transcriptomic profiling revealed activation of TNFR2-associated signaling and upregulation of immune-regulatory pathways. These findings identify peptide UMR2–705 as a selective, peptide-based TNFR2 agonist with potent Treg-expanding and anti-inflammatory activities, supporting its potential as a therapeutic candidate for autoimmune and inflammatory disorders.
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1696587
Open AccessA novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells
CD4 + Foxp3 + regulatory T cells (Tregs) are essential for maintaining immune tolerance, and selective expansion of Tregs via TNFR2 signaling represents a promising therapeutic approach for autoimmune and inflammatory diseases. Here, we report the identification and characterization of UMR2-705, a novel TNFR2 agonist discovered through phage display screening. In vitro , peptide UMR2–705 selectively promoted Treg proliferation in both human peripheral blood mononuclear cells and murine CD4 + T cell cultures without stimulating conventional CD4 + effector or CD8 + T cells. This effect was abrogated by the TNFR2-specific blocking antibody TR75-54.7, indicating its TNFR2 dependency. In vivo , administration of peptide UMR2–705 expanded Tregs in murine spleen and lymph nodes, attenuated LPS-induced systemic cytokine release (IL-6, TNF-α, IL-17A) in serum, and preserved immune homeostasis during systemic inflammation through TNFR2-dependent modulation of the regulatory compartment. Transcriptomic profiling revealed activation of TNFR2-associated signaling and upregulation of immune-regulatory pathways. These findings identify peptide UMR2–705 as a selective, peptide-based TNFR2 agonist with potent Treg-expanding and anti-inflammatory activities, supporting its potential as a therapeutic candidate for autoimmune and inflammatory disorders.
- Open Access
- 22 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (9) , 1212
Chinese Medicine-Derived Natural Compounds and Intestinal Regeneration: Mechanisms and Experimental Evidence
Intestinal regeneration is essential for maintaining epithelial integrity and repairing mucosal damage caused by inflammation, infections, or injuries. Traditional Chinese Medicine (TCM) has long utilized herbal remedies for gastrointestinal disorders, and accumulating evidence highlights that natural compounds derived from TCM possess significant regenerative potential. This review summarizes the multifaceted mechanisms by which these bioactive compounds promote intestinal healing. Key actions include the stimulation of intestinal stem cell (ISC) proliferation and differentiation, the modulation of inflammatory responses, the reinforcement of epithelial barrier integrity, the attenuation of oxidative stress, and the reshaping of the gut microbiota. Representative compounds such as Astragalus polysaccharides, berberine, curcumin, puerarin, and flavonoids like quercetin exhibit these effects through signaling pathways, including HIF-1, Wnt/β-catenin, NF-κB, Nrf2, and IL-22. Evidence from in vitro organoid models and in vivo studies in colitis, radiation injury, antibiotic-associated diarrhea, and intestinal dysmotility and diarrhea models demonstrates that these compounds enhance crypt villus regeneration, preserve tight junctions, and improve clinical outcomes. The holistic, multi-target actions of Chinese medicine-derived natural products make them promising candidates for therapeutic strategies aimed at intestinal repair. Further clinical validation and mechanistic studies are warranted to facilitate their integration into modern gastrointestinal medicine.
- 22 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (9) , 1212
Open AccessChinese Medicine-Derived Natural Compounds and Intestinal Regeneration: Mechanisms and Experimental Evidence
Intestinal regeneration is essential for maintaining epithelial integrity and repairing mucosal damage caused by inflammation, infections, or injuries. Traditional Chinese Medicine (TCM) has long utilized herbal remedies for gastrointestinal disorders, and accumulating evidence highlights that natural compounds derived from TCM possess significant regenerative potential. This review summarizes the multifaceted mechanisms by which these bioactive compounds promote intestinal healing. Key actions include the stimulation of intestinal stem cell (ISC) proliferation and differentiation, the modulation of inflammatory responses, the reinforcement of epithelial barrier integrity, the attenuation of oxidative stress, and the reshaping of the gut microbiota. Representative compounds such as Astragalus polysaccharides, berberine, curcumin, puerarin, and flavonoids like quercetin exhibit these effects through signaling pathways, including HIF-1, Wnt/β-catenin, NF-κB, Nrf2, and IL-22. Evidence from in vitro organoid models and in vivo studies in colitis, radiation injury, antibiotic-associated diarrhea, and intestinal dysmotility and diarrhea models demonstrates that these compounds enhance crypt villus regeneration, preserve tight junctions, and improve clinical outcomes. The holistic, multi-target actions of Chinese medicine-derived natural products make them promising candidates for therapeutic strategies aimed at intestinal repair. Further clinical validation and mechanistic studies are warranted to facilitate their integration into modern gastrointestinal medicine.
- Top Cited Papers
- 16 November 2022
- Published by Springer Nature in Nature
- Vol. 611 (7937) , 818-826
T cells specific for α-myosin drive immunotherapy-related myocarditis
Immune-related adverse events, particularly severe toxicities such as myocarditis, are major challenges to the utility of immune checkpoint inhibitors (ICIs) in anticancer therapy1. The pathogenesis of ICI-associated myocarditis (ICI-MC) is poorly understood. Pdcd1–/–Ctla4+/– mice recapitulate clinicopathological features of ICI-MC, including myocardial T cell infiltration2. Here, using single-cell RNA and T cell receptor (TCR) sequencing of cardiac immune infiltrates from Pdcd1–/–Ctla4+/– mice, we identify clonal effector CD8+ T cells as the dominant cell population. Treatment with anti-CD8-depleting, but not anti-CD4-depleting, antibodies improved the survival of Pdcd1–/–Ctla4+/– mice. Adoptive transfer of immune cells from mice with myocarditis induced fatal myocarditis in recipients, which required CD8+ T cells. The cardiac-specific protein α-myosin, which is absent from the thymus3,4, was identified as the cognate antigen source for three major histocompatibility complex class I-restricted TCRs derived from mice with fulminant myocarditis. Peripheral blood T cells from three patients with ICI-MC were expanded by α-myosin peptides. Moreover, these α-myosin-expanded T cells shared TCR clonotypes with diseased heart and skeletal muscle, which indicates that α-myosin may be a clinically important autoantigen in ICI-MC. These studies underscore the crucial role for cytotoxic CD8+ T cells, identify a candidate autoantigen in ICI-MC and yield new insights into the pathogenesis of ICI toxicity.
- 16 November 2022
- Published by Springer Nature in Nature
- Vol. 611 (7937) , 818-826
Top Cited PapersT cells specific for α-myosin drive immunotherapy-related myocarditis
Immune-related adverse events, particularly severe toxicities such as myocarditis, are major challenges to the utility of immune checkpoint inhibitors (ICIs) in anticancer therapy1. The pathogenesis of ICI-associated myocarditis (ICI-MC) is poorly understood. Pdcd1–/–Ctla4+/– mice recapitulate clinicopathological features of ICI-MC, including myocardial T cell infiltration2. Here, using single-cell RNA and T cell receptor (TCR) sequencing of cardiac immune infiltrates from Pdcd1–/–Ctla4+/– mice, we identify clonal effector CD8+ T cells as the dominant cell population. Treatment with anti-CD8-depleting, but not anti-CD4-depleting, antibodies improved the survival of Pdcd1–/–Ctla4+/– mice. Adoptive transfer of immune cells from mice with myocarditis induced fatal myocarditis in recipients, which required CD8+ T cells. The cardiac-specific protein α-myosin, which is absent from the thymus3,4, was identified as the cognate antigen source for three major histocompatibility complex class I-restricted TCRs derived from mice with fulminant myocarditis. Peripheral blood T cells from three patients with ICI-MC were expanded by α-myosin peptides. Moreover, these α-myosin-expanded T cells shared TCR clonotypes with diseased heart and skeletal muscle, which indicates that α-myosin may be a clinically important autoantigen in ICI-MC. These studies underscore the crucial role for cytotoxic CD8+ T cells, identify a candidate autoantigen in ICI-MC and yield new insights into the pathogenesis of ICI toxicity.
- Open Access
- 4 September 2022
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-17
Protective effect of α7 nicotinic acetylcholine receptor activation on experimental colitis and its mechanism
Background: Inflammatory bowel disease (IBD) is a common chronic remitting disease with no satisfactory treatment. The aim of this study was to investigate the protective effect of α7 nicotinic acetylcholine receptor (α7nAChR), and to determine the underlying mechanism of its activity. Methods: The expression and distribution of α7nAChR in the intestinal tissue of patients with ulcerative colitis and Crohn’s disease were analyzed. The effects of vagal excitation on murine experimental colitis were investigated. The colitis model was induced in C57BL/6 mice by the administration of 3% dextran sulfate sodium (DSS). The therapeutic group received treatment with the α7nAChR agonist PNU-282987 by intraperitoneal injection. Results: Our results showed that there was significantly increased expression of α7nAChR in colitis and Crohn’s disease intestinal tissue, and its expression was mainly located in macrophages and neutrophils, which were extensively infiltrated in the disease status. Treatment with an α7nAChR agonist potently ameliorated the DSS-induced illness state, including weight loss, stool consistency, bleeding, colon shortening, and colon histological injury. α7nAChR agonist exerted anti-inflammatory effects in DSS colitis mice by suppressing the secretion of multiple types of proinflammatory factors, such as IL6, TNFα, and IL1β, and it also inhibited the colonic infiltration of inflammatory cells by blocking the DSS-induced overactivation of the NF-κB and MAPK signaling pathways. Mechanistically, activation of α7nAChR decreased the number of infiltrated M1 macrophages in the colitis intestine and inhibited the phagocytosis ability of macrophages, which were activated in response to LPS stimulation. Conclusion: Thus, an α7nAChR agonist ameliorated colonic pathology and inflammation in DSS-induced colitis mice by blocking the activation of inflammatory M1 macrophages.
- 4 September 2022
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-17
Open AccessProtective effect of α7 nicotinic acetylcholine receptor activation on experimental colitis and its mechanism
Background: Inflammatory bowel disease (IBD) is a common chronic remitting disease with no satisfactory treatment. The aim of this study was to investigate the protective effect of α7 nicotinic acetylcholine receptor (α7nAChR), and to determine the underlying mechanism of its activity. Methods: The expression and distribution of α7nAChR in the intestinal tissue of patients with ulcerative colitis and Crohn’s disease were analyzed. The effects of vagal excitation on murine experimental colitis were investigated. The colitis model was induced in C57BL/6 mice by the administration of 3% dextran sulfate sodium (DSS). The therapeutic group received treatment with the α7nAChR agonist PNU-282987 by intraperitoneal injection. Results: Our results showed that there was significantly increased expression of α7nAChR in colitis and Crohn’s disease intestinal tissue, and its expression was mainly located in macrophages and neutrophils, which were extensively infiltrated in the disease status. Treatment with an α7nAChR agonist potently ameliorated the DSS-induced illness state, including weight loss, stool consistency, bleeding, colon shortening, and colon histological injury. α7nAChR agonist exerted anti-inflammatory effects in DSS colitis mice by suppressing the secretion of multiple types of proinflammatory factors, such as IL6, TNFα, and IL1β, and it also inhibited the colonic infiltration of inflammatory cells by blocking the DSS-induced overactivation of the NF-κB and MAPK signaling pathways. Mechanistically, activation of α7nAChR decreased the number of infiltrated M1 macrophages in the colitis intestine and inhibited the phagocytosis ability of macrophages, which were activated in response to LPS stimulation. Conclusion: Thus, an α7nAChR agonist ameliorated colonic pathology and inflammation in DSS-induced colitis mice by blocking the activation of inflammatory M1 macrophages.
- Open Access
- 15 April 2014
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 9 (1) , 28
Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study
The optimal transfusion protocol remains unknown in the trauma setting. This retrospective cohort study aimed to determine if goal-directed transfusion protocol based on standard thrombelastography (TEG) is feasible and beneficial in patients with abdominal trauma.
- 15 April 2014
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 9 (1) , 28
Open AccessGoal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study
The optimal transfusion protocol remains unknown in the trauma setting. This retrospective cohort study aimed to determine if goal-directed transfusion protocol based on standard thrombelastography (TEG) is feasible and beneficial in patients with abdominal trauma.